Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update

Gastrointestinal Endoscopy

Volumn 85, Issue 2, 2017, Pages 282-294.e1

  Petersen, Bret T ^a   Cohen, Jonathan ^a   Hambrick, Ralph David ^a   Buttar, Navtej ^a   Greenwald, David A ^a   Buscaglia, Jonathan M ^a   Collins, James ^a   Eisen, Glenn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLASSIFICATION; CLEANING; DEVICE MAINTENANCE; DIGESTIVE ENDOSCOPE; DISEASE TRANSMISSION; DISINFECTION; DUODENOSCOPE; EVIDENCE BASED PRACTICE; FIBEROSCOPE; HUMAN; INFECTION PREVENTION; INSTRUMENT STERILIZATION; MEDICAL DEVICE REGULATION; MEDICAL SOCIETY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHELF LIFE; DEVICES; DIGESTIVE TRACT ENDOSCOPY; ENDOSCOPE; EQUIPMENT CONTAMINATION; RECYCLING; STANDARDS;

DISINFECTION; ENDOSCOPES; ENDOSCOPES, GASTROINTESTINAL; ENDOSCOPY, DIGESTIVE SYSTEM; EQUIPMENT CONTAMINATION; EQUIPMENT REUSE; HUMANS; SOCIETIES, MEDICAL; STERILIZATION;

EID: 85008612486     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2016.10.002     Document Type: Article

References (140)

1. 1 Nelson, D.B., Jarvis, W.R., Rutala, W.A., et al. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Gastrointest Endosc 58 (2003), 1–8.
2. 2 Nelson, D.B., Jarvis, W.R., Rutala, W.A., et al. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Infect Control Hosp Epidemiol 24 (2003), 532–537.
3. 3 ASGE Technology Committee, Desilets, D., Kaul, V., Tierney, W.M., et al. Automated endoscope reprocessors. Gastrointest Endosc 72 (2010), 675–680.
4. 4 ASGE Technology Committee, Croffie, J., Carpenter, S., Chuttani, R., ASGE technology status evaluation report: disposable endoscopic accessories. Gastrointest Endosc 62 (2005), 477–479.
5. 5 Petersen, B.T., Gaining perspective on reprocessing of GI endoscopes. Gastrointest Endosc 50 (1999), 287–291.
6. 6 Nelson, D.B., Recent advances in epidemiology and prevention of gastrointestinal endoscopy related infections. Curr Opin Infect Dis 18 (2005), 326–330.
7. 7 Rutala, W.A., Weber, D.J., Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis 39 (2004), 702–709.
8. 8 Centers for Disease Control and Prevention. Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic—Nevada, 2007. MMWR 57 (2008), 513–517.
9. 9 Department of Veterans Affair. Office of Inspector General. Healthcare inspection. Use and reprocessing of flexible fiberoptic endoscopes at VA medical facilities. Report No. 09-01784-146. June 16, 2009:1-45.
10. 10 Schaefer, M.K., Jhung, M., Dahl, M., et al. Infection control assessment of ambulatory surgical centers. JAMA 303 (2010), 2273–2279.
11. 11 Petersen, B.T., Chennat, J., Cohen, J., et al. Multisociety guideline on reprocessing flexible gastrointestinal endoscopes, 2011. Gastrointest Endosc 73 (2011), 1075–1368.
12. 12 Petersen, B.T., Chennat, J., Cohen, J., et al. Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Control Hosp Epidemiol 32 (2011), 527–537.
13. 13 Favero, M.S., Bond, W.W., Disinfection of medical and surgical materials. Block, S.S., (eds.) Disinfection, sterilization, and preservation, 2001, Lippincott Williams & Wilkins, Philadelphia, PA, 881–917.
14. 14 Everhart JE. The burden of digestive disease in the United States. U.S. Department of Health and Human Services 2008: NIH Publication No. 09-6443.
15. 15 Spach, D.H., Silverstein, F.E., Stamm, W.E., Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 118 (1993), 117–128.
16. 16 Nelson, D.B., Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc 57 (2003), 695–711.
17. 17 McCool S, Clarke L, Querry A, et al. Carbapenem-resistant Enterobacteriaceae (CRE) Klebsiella pneumonia (KP) cluster analysis associated with GI scopes with elevator channel. Presented at ID Week, October 2-6, 2013, Abstract 1619.
18. 18 Smith, Z.L., Young, S.O., Saeian, K., et al. Transmission of carbapenem-resistant Enterobacteriaciae during ERCP: time to revisit the current reprocessing guidelines. Gastrointest Endosc 81 (2015), 1041–1045.
19. 19 Available at: https://www.uclahealth.org/news/ucla-statement-on-notification-of-patients-regarding-endoscopic-procedures. Accessed April 24, 2015.
20. 20 Available at: http://www.cedars-sinai.edu/About-Us/News/News-Releases-2015/Media-Statement-Regarding-CRE-and-Duodenoscope.aspx. Accessed April 24, 2015.
21. 21 Epstein, L., Hunter, J.C., Arwady, M.A., et al. New Delhi metallo-β-lactamase–producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 312 (2014), 1447–1455.
22. 22 Wendorf, K.A., Kay, M., Baliga, C., et al. Endoscopic retrograde cholangiopancreatography–associated ampC Escherichia coli outbreak. Infect Control Hosp Epidemiol 36 (2015), 634–642.
23. 23 Muscarella, L.F., Recommendations for preventing hepatitis C virus infection: analysis of a Brooklyn endoscopy clinic's outbreak. Infect Control Hosp Epidemiol, 22, 2001, 669.
24. 24 Bronowicki, J.-P., Venard, V., Botté, C., et al. Patient-to patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 337 (1997), 237–240.
25. 25 Le Pogam, S., Gondeau, A., Bacq, Y., Nosocomial transmission of hepatitis C virus. Ann Intern Med, 131, 1999, 794.
26. 26 Tennenbaum, R., Colardelle, P., Chochon, M., et al. Hepatitis C after retrograde cholangiography. Gastroenterol Clin Biol 17 (1993), 763–775.
27. 27 Lo Passo, C., Pernice, I., Celeste, A., et al. Transmission of Trichosporon asahii esophagitis by a contaminated endoscope. Mycoses 44 (2001), 13–21.
28. 28 Yu-Hsien, L., Te-Li, C., Chien-Pei, C., et al. Nosocomial Acinetobacter genomic species 13TU endocarditis following an endoscopic procedure. Intern Med 47 (2008), 799–802.
29. 29 Nelson, D.B., Hepatitis C virus cross-infection during endoscopy: is it the “tip of the iceberg” or the absence of ice?. Gastrointest Endosc 65 (2007), 589–591.
30. 30 Holodniy, M.L., Oda, G., Schirmer, P.L., et al. Results from a large-scale epidemiologic look-back investigation of improperly reprocessed endoscopy equipment. Infect Control Hosp Epidemiol 33 (2012), 649–656.
31. 31 MAUDE Database. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm. Accessed October 10, 2015.
32. 32 Dirlam Langlay, A.M., Ofstead, C.L., Mueller, N.J., et al. Reported gastrointestinal endoscope reprocessing lapses: the tip of the iceberg. Am J Infect Control 41 (2013), 1188–1194.
33. 33 Verfaillie, C.J., Bruno, M.J., Voor in ’t holt, A.F., et al. Withdrawal of a novel-design duodenoscope ends outbreak of a VIM-2-producing Pseudomonas aeruginosa. Endoscopy, 47, 2015, 502.
34. 34 Gastmeier, P., Vonberg, R.P., Klebsiella spp. in endoscopy-associated infections: we may only be seeing the tip of the iceberg. Infection 42 (2014), 15–21.
35. 35 Petersen, B.T., Duodenoscope reprocessing: risks and options coming into view. Gastrointest Endosc 82 (2015), 484–487.
36. 36 U.S. Senate Health, Education, Labor, and Pensions Committee Minority Staff Report. Preventable tragedies: superbugs and how ineffective monitoring of medical device safety fails patients. Available at: http://www.help.senate.gov/imo/media/doc/Duodenoscope%20Investigation%20FINAL%20Report.pdf. Accessed May 7, 2016.
37. 37 Food and Drug Administration. Reprocessing medical devices in health care settings: validation methods and labeling guidance for industry and Food and Drug Administration staff. March 17, 2015. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM253010.pdf. Accessed October 10, 2015.
38. 38 Rutala WA, Weber DJ, and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008. Available at: http://www.cdc.gov/hicpac/Disinfection_Sterilization/3_0disinfectEquipment.html. Accessed October 10, 2015.
39. 39 Banerjee, S., Shen, B., Nelson, D.B., et al. Infection control during GI endoscopy. Gastrointest Endosc 67 (2008), 781–790.
40. 40 Standards of infection prevention in reprocessing flexible gastrointestinal endoscopes. 2015. Available at: https://www.sgna.org/Portals/0/Standards%20for%20reprocessing%20endoscopes_FINAL_2.22.pdf.
41. 41 Reprocessing of endoscopic accessories and valves. 2014. Available at: https://www.sgna.org/Portals/0/Education/PDF/Position-Statements/Reprocessingvalvesdocument_FINAL.pdf.
42. 42 Guideline for use of high-level disinfectants and sterilants for reprocessing flexible gastrointestinal endoscopes. SGNA Practice Committee 2013-14. Gastroenterol Nurs 38 (2015), 70–80.
43. 43 Van Wicklin, S.A., Connor, R., Spry, C., Guideline for processing flexible endoscopes. Guidelines for perioperative practice, 2016, AORN Inc., Denver, CO.
44. 44 Alvarado, C.J., Reichelderfer, M., APIC guidelines for infection prevention and control in flexible endoscopy. Am J Infect Control 28 (2000), 138–155.
45. 45 Hookey, L., Armstrong, D., Enns, R., et al. Summary of guidelines for infection prevention and control for flexible gastrointestinal endoscopy. Can J Gastroenterol 27 (2013), 347–350.
46. 46 British Society of Gastroenterology Endoscopy Committee. Guidelines for decontamination of equipment for gastrointestinal endoscopy. 2014. Available at: http://www.bsg.org.uk/clinical-guidance/general/guidelines-for-decontamination-of-equipment-for-gastrointestinal-endoscopy.html. Accessed October 12, 2015.
47. 47 Flexible and semi-rigid endoscope processing in health care facilities. ANSI/AAMI ST91:2015.
48. 48 Food and Drug Administration. Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning: FDA safety communication. February 19, 2015, updated February 23 and March 4, 2015. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm434871.htm. Accessed October 10, 2015.
49. 49 Food and Drug Administration. Supplemental measures to enhance duodenoscope reprocessing: FDA safety communication. August 4, 2015. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454766.htm. Accessed October 10, 2015.
50. 50 US Food and Drug Administration. Brief summary of the gastroenterology and urology devices panel meeting, May 14-15, 2015. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Gastroenterology-UrologyDevicesPanel/UCM447407.pdf. Accessed October 10, 2015.
51. 51 Moses, F.M., Lee, J.S., Current GI endoscope disinfection and QA practices. Dig Dis Sci 49 (2004), 1791–1797.
52. 52 FDA News Release: FDA orders duodenoscope manufacturers to conduct post-market surveillance studies in health care facilities. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465639.htm. Accessed October 14, 2015.
53. 53 Osborne, S., Reynolds, S., George, N., et al. Challenging endoscopy reprocessing guidelines: a prospective study investigating the safe shelf life of flexible endoscopes in a tertiary gastroenterology unit. Endoscopy 39 (2007), 825–830.
54. 54 Rejchrt, S., Cermak, P., Pavlatova, L., et al. Bacteriologic testing of endoscopes after high-level disinfection. Gastrointest Endosc 60 (2004), 76–78.
55. 55 Vergis, A.S., Thomson, D., Pieroni, P., et al. Reprocessing flexible gastrointestinal endoscopes after a period of disuse: is it necessary?. Endoscopy 39 (2007), 737–739.
56. 56 Brock, A.S., Steed, L.L., Freeman, J., et al. Endoscope storage time: assessment of microbial colonization up to 21 days after reprocessing. Gastrointest Endosc 81 (2015), 1150–1154.
57. 57 Ingram, J., Gaines, P., Kite, R., et al. Evaluation of medically significant bacteria in colonoscopes after 8 weeks of shelf life in open air storage. Gastroenterol Nurs 36 (2013), 106–111.
58. 58 Schmelzer M, Daniels G, Hough H. The length of time that flexible endoscopes which have undergone reprocessing with high-level disinfection can safely be stored before use: a systematic review. JBI Database of Systematic Reviews and Implementation Reports 2015, 13;9:187-243.
59. 59 Greenwald, D., Endoscopic hang time: Can we get some clarity?. Gastrointest Endosc 81 (2015), 1155–1157.
60. 60 Grandval, P., Hautefeuille, G., Marchetti, B., et al. Evaluation of a storage cabinet for heat-sensitive endoscopes in a clinical setting. J Hosp Infect 84 (2013), 71–76.
61. 61 Pineau, L., Villard, E., Duc, D.L., et al. Endoscope drying/storage cabinet: interest and efficacy. J Hosp Infect 68 (2008), 59–65.
62. 62 Saliou, P., Cholet, F., Jézéquel, J., et al. The use of channel-purge storage for gastrointestinal endoscopes reduces microbial contamination. Infect Control Hosp Epidemiol 36 (2015), 1100–1102.
63. 63 Food and Drug Administration. Mitigating the risk of cross contamination from valves and accessories used for irrigation through flexible gastrointestinal endoscopes draft guidance for industry and Food and Drug Administration staff. Available at: http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddev-gen/documents/document/ucm430550.pdf. Accessed October 10, 2015.
64. 64 Taylor A, Jones D, Everts R, et al, eds. Infection Control in Gastrointestinal Endoscopy, 3rd ed. Gastroenterological Society of Australia. Australia Gastrointestinal Endoscopy Association, and Gastroenterological Nurses College of Australia. Victoria, AUS, 2010.
65. 65 Beilenhoff, E.U., Neumann, C.S., Rey, J.F., et al., and the ESGE Guidelines Committee. ESGE±ESGENA guideline: cleaning and disinfection in gastrointestinal endoscopy: Update 2008. Endoscopy 40 (2008), 939–957.
66. 66 Beilenhoff, U., Neumann, C., Rey, J.F., et al. ESGE±ESGENA guideline for quality assurance in reprocessing: microbiological surveillance testing in endoscopy. Endoscopy 39 (2007), 175–181.
67. 67 Deva, A.K., Vickery, K., Zou, J., et al. Detection of persistent vegetative bacteria and amplified viral nucleic acid from in-use testing of gastrointestinal endoscopes. J Hosp Infect 39 (1998), 149–157.
68. 68 Moses, F.M., Lee, J.S., Surveillance cultures to monitor quality of gastrointestinal endoscope reprocessing. Am J Gastroenterol 98 (2003), 77–81.
69. 69 Tunuguntla, A., Sullivan, M., Monitoring quality of flexible endoscope disinfection by microbiologic surveillance cultures. Tenn Med 97 (2004), 453–456.
70. 70 US Food and Drug Administration. Interim protocol for healthcare facilities regarding surveillance for bacterial contamination of duodenoscopes after reprocessing. Available at: http://www.cdc.gov/hai/organisms/cre/cre-duodenoscope-surveillance-protocol.html. Accessed October 10, 2015.
71. 71 Sharp SE. ASM Public and Scientific Affairs Board Committee on Laboratory Practices, Susan E. Sharp, Ph.D., DABMM, FAAM, Chair. April 2015.
72. 72 Ross, A.S., Baliga, C., Verma, P., et al. A quarantine process for the resolution of duodenoscope-associated transmission of multidrug-resistant Escherichia coli. Gastrointest Endosc 82 (2015), 477–483.
73. 73 Obee, P.C., Griffith, C.J., Cooper, R.A., et al. Real-time monitoring in managing the decontamination of flexible gastrointestinal endoscopes. Am J Infect Control 33 (2005), 202–206.
74. 74 Komanduri, S., Abu Dayyeh, B.K., Bhat, Y.M., et al. Technologies for monitoring the quality of endoscope reprocessing. ASGE Technology Committee. Gastrointest Endosc 80 (2014), 369–373.
75. 75 Alfa, M.J., Olson, N., Murray, B.L., Comparison of clinically relevant benchmarks and channel sampling methods used to assess manual cleaning compliance for flexible gastrointestinal endoscopes. Am J Infect Control 42 (2014), e1–e5.
76. 76 Petersen, B.T., Monitoring of endoscope reprocessing: accumulating data but best practices remain undefined. Infect Control Hosp Epidemiol 35 (2014), 995–997.
77. 77 Alfa, M.J., Fatima, I., Olson, N., Validation of adenosine triphosphate to audit manual cleaning of flexible endoscope channels. Am J Infect Control 41 (2013), 245–248.
78. 78 Alfa, M.J., DeGagne, P., Olson, N., et al. EVOTECH endoscope cleaner and reprocessor(ECR) simulated-use and clinical-use evaluation of cleaning efficacy. BMC Infect Dis, 10, 2010, 200.
79. 79 Available at: http://www.fda.gov/medicaldevices/productsandmedicalprocedures/reprocessingofreusablemedicaldevices/ucm483896.htm#effective. Accessed February 16, 2016.
80. 80 Lee, D.H., Kim, D.B., Kim, H.Y., et al. Increasing potential risks of contamination from repetitive use of endoscope. Am J Infect Control 43 (2015), e13–e17.
81. 81 Rutala, W.A., Weber, D.J., Commentary: ERCP scopes: what can we do to prevent infections?. Infect Control Hosp Epidemiol 36 (2015), 643–648.
82. 82 Available at: http://www.fda.gov/medicaldevices/productsandmedicalprocedures/reprocessingofreusablemedicaldevices/ucm454630.htm. Accessed February 16, 2016.
83. 83 Food and Drug Administration. Preventing Cross-contamination in endoscope processing. Safety communication from FDA, CDC, and the VA. November 19, 2009. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm190273.htm. Accessed October 10, 2015.
84. 84 Alfa, M.J., Jackson, M., A new hydrogen peroxide-based medical-device detergent with germicidal properties: comparison with enzymatic cleaners. Am J Infect Control 29 (2001), 168–177.
85. 85 Zühlsdorf, B., Floss, H., Martiny, H., Efficacy of 10 different cleaning processes in a washer-disinfector for flexible endoscopes. Journal of Hospital Infection 56 (2004), 305–311.
86. 86 SGNA Practice Committee. Reprocessing of endoscopic accessories and valves. SGNA J 29 (2007), 394–395.
87. 87 Food and Drug Administration. FDA-cleared sterilants and high level disinfectants with general claims for processing reusable medical and dental devices. March 2009. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ReprocessingofSingle-UseDevices/ucm133514.htm. Accessed October 10, 2015.
88. 88 Rutala, W.A., APIC guideline for selection and use of disinfectants. Am J Infect Control 24 (1996), 313–342.
89. 89 Urayama, S., Kozarek, R.A., Sumida, S., et al. Mycobacteria and glutaraldehyde: is high-level disinfection of endoscopes possible?. Gastrointest Endosc 43 (1996), 451–456.
90. 90 Vesley, D., Melson, J., Patricia, S., Microbial bioburden in endoscope reprocessing and an in-use evaluation of the high-level disinfection capabilities of Cidex PA. Gastroenterol Nurs 22 (1999), 63–68.
91. 91 Collins, F.M., Kinetics of tuberculocidal response by alkaline glutaraldehyde in solution and on an inert surface. J Appl Bacteriol 61 (1986), 87–93.
92. 92 Collins, F.M., Bactericidal activity of alkaline glutaraldehyde solution against a number of atypical mycobacterial species. J Appl Bacteriol 61 (1986), 247–251.
93. 93 Ascenzi, J.M., Ezzell, R.J., Wendt, T.M., A more accurate method for measurement of tuberculocidal activity of disinfectants. Appl Environ Microbiol 53 (1987), 2189–2192.
94. 94 Collins, F.M., Use of membrane filters for measurement of mycobacterial activity of alkaline glutaraldehyde solution. Appl Environ Microbiol 53 (1987), 737–739.
95. 95 Best, M., Sattar, S.A., Springthorpe, V.S., et al. Efficacies of selected disinfectants against Mycobacterium tuberculosis. J Clin Microbiol 28 (1990), 2234–2239.
96. 96 Cole, E.C., Rutala, W.A., Nessen, L., et al. Effect of methodology, dilution, and exposure time on the tuberculocidal activity of glutaraldehyde-based disinfectants. Appl Environ Microbiol 56 (1990), 1813–1817.
97. 97 Hanson, P.J.V., Gor, D., Jeffries, D.J., et al. Elimination of high titre HIV from fiberoptic endoscopes. Gut 31 (1990), 657–659.
98. 98 Hanson, P.J., Jeffries, D.J., Collins, J.V., Viral transmission and fibreoptic endoscopy. J Hosp Infect 18 (1991), 136–140.
99. 99 Rutala, W.A., Cole, E.C., Wannamaker, N.S., et al. Inactivation of Mycobacterium tuberculosis and Mycobacterium bovis by 14 hospital disinfectants. Am J Med 91 (1991), 267S–271S.
100. 100 Hanson, P.J., Chadwick, M.V., Gaya, H., et al. A study of glutaraldehyde disinfection of fibreoptic bronchoscopes experimentally contaminated with Mycobacterium tuberculosis. J Hosp Infect 22 (1992), 137–142.
101. 101 Best, M., Springthorpe, V.S., Sattar, S.A., Feasibility of a combined carrier test for disinfectants: studies with a mixture of five types of microorganisms. Am J Infect Control 22 (1994), 152–162.
102. 102 Jackson, J., Leggett, J.E., Wilson, D., et al. Mycobacterium gordonae in fiberoptic bronchoscopes. Am J Infect Control 24 (1996), 19–23.
103. 103 Chanzy, B., Duc-Bin, D.L., Rousset, B., et al. Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointest Endosc 50 (1999), 147–151.
104. 104 Fuselier, H.A., Mason, C., Liquid sterilization versus high level disinfection in the urologic office. Urology 50 (1997), 337–340.
105. 105 Rutala, W.A., Weber, D.J., Disinfection of endoscopes: review of new chemical sterilants used for high-level disinfection. Infect Control Hosp Epidemiol 20 (1999), 69–76.
106. 106 Rutala, W.A., Weber, D.J., Importance of lumen flow in liquid chemical sterilization. Am J Infect Control 20 (1999), 458–459.
107. 107 Sorin, M., Segal-Maurer, S., Urban, C., et al. Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor. Infect Control Hosp Epidemiol 20 (2001), 514–516.
108. 108 Centers for Disease Control and Prevention. Bronchoscopy-related infections and pseudoinfections: New York, 1996 and 1998. MMWR 48 (1999), 557–560.
109. 109 Allen, J.I., Pseudomonas aeruginosa infection during endoscopy: reply. Gastroenterology, 93, 1987, 1451.
110. 110 Streulens, M.J., Rost, F., Deplano, A., et al. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med 95 (1993), 489–498.
111. 111 O'Connor, H.J., Babb, J.R., Ayliffe, G.A.J., Pseudomonas aeruginosa infection during endoscopy. Gastroenterology, 93, 1987, 1451.
112. 112 Alvarado, C.J., Stolz, S.M., Maki, D.G., Nosocomial infections from contaminated endoscopes: a flawed automated endoscope washer. An investigation using molecular epidemiology. Am J Med 91 (1991), 272S–280S.
113. 113 Centers for Disease Control and Prevention. Nosocomial infection and pseudoinfection from contaminated endoscopes and bronchoscopes: Wisconsin and Missouri. MMWR 40 (1991), 675–678.
114. 114 Fraser, V.J., Jones, M., Murray, P.R., et al. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am Rev Respir Dis 145 (1992), 853–855.
115. 115 Cronmiller, J.R., Nelson, D.K., Salman, G., et al. Antimicrobial efficacy of endoscopic disinfection procedures: a controlled, multifactorial investigation. Gastrointest Endosc 50 (1999), 152–158.
116. 116 Gerding, D.N., Peterson, L.R., Vennes, J.A., Cleaning and disinfection of fiberoptic endoscopes: evaluation of glutaraldehyde exposure time and forced-air drying. Gastroenterology 83 (1982), 613–618.
117. 117 Allen, J.I., Allen, M.O.C., Olson, M.M., et al. Pseudomonas infection of the biliary system resulting from use of a contaminated endoscope. Gastroenterology 92 (1987), 759–763.
118. 118 Alfa, M.J., Sitter, D.L., In hospital evaluation of contamination of duodenoscopes: a quantitative assessment of the effects of drying. J Hosp Infect 19 (1991), 89–98.
119. 119 Muscarella, L.F., Inconsistencies in endoscope-reprocessing and infection-control guidelines: the importance of endoscope drying. Am J Gastroenterol 101 (2006), 2147–2154.
120. 120 Noy, M.F., Harrison, L., Holmes, G.K.T., et al. The significance of bacterial contamination of fiberoptic endoscopes. J Hosp Infect 1 (1980), 53–61.
121. 121 Meenhorst, P.L., Reingold, A.L., Groothuis, D., Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis 152 (1985), 356–364.
122. 122 Wright, E.P., Collins, C.H., Yates, M.D., Mycobacterium xenopi and Mycobacterium kansasii in a hospital water supply. J Hosp Infect 6 (1985), 175–178.
123. 123 Rutala, W.A., Weber, D.J., Water as a reservoir of nosocomial pathogens. Infect Control Hosp Epidemiol 18 (1997), 609–616.
124. 124 Wallace, R.J., Brown, B.A., Driffith, D.E., Nosocomial outbreaks/pseudo outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 52 (1998), 453–490.
125. 125 SGNA Practice Committee. Reprocessing of water bottles used during endoscopy. J SGNA 29 (2006), 396–397.
126. 126 Mbisi, J.N., Springthorpe, V.S., Sattar, S.A., et al. Bactericidal, virucidal, and mycobactericidal activities of reused alkaline glutaraldehyde in an endoscopy unit. J Clin Microbiol 31 (1993), 2988–2995.
127. 127 Occupational Safety and Health Administration. Air contaminants, final rule. 58 Federal Register 35338-35351 (1993).
128. 128 Weber, D.J., Rutala, W.A., Occupational risks associated with the use of selected disinfectants and sterilants. Rutala, W.A., (eds.) Disinfection, sterilization, and antisepsis in healthcare, 1998, Polyscience, Champlain, NY, 211–226.
129. 129 American Conference of Governmental Industrial Hygienists. Threshold limit values for chemical substances and physical agents and biologic exposure indices. 7th Edition. Cincinnati, American Conference of Governmental Industrial Hygienists, 2001.
130. 130 American Society for Gastrointestinal Endoscopy, Establishment of gastrointestinal endoscopy areas: guidelines for clinical application. Gastrointest Endosc 50 (1999), 910–912.
131. 131 Occupational Safety and Health Administration. Hazard communication standard, 29 CFR 1910.1200.
132. 132 Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens, final rule. 56 Federal Register 64003-64182 (1991).
133. 133 Carr-Locke, D.L., Conn, M.I., Faigel, D.O., et al. Personal protective equipment. Gastrointest Endosc 49 (1999), 854–857.
134. 134 Siegel JD, Rhinehart E, Jackson M, et al. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. 2007. Available at: http://www.cdc.gov/hicpac/pdf/Disinfection_Sterilization/Pages68_72Disinfection_Nov_2008.pdf. Accessed Nov 25, 2010.
135. 135 Bond, W.W., Hedrick, E.R., Microbiological culturing of environment and medical-device surfaces. Isenberg, H.D., Gilchrist, M.J.R., (eds.) Clinical microbiology procedures handbook, 1992, American Society for Microbiology, Washington, DC p. 11.0.1-9.
136. 136 Muscarella, L.F., Infection control and its application to the administration of intravenous medications during gastrointestinal endoscopy. Am J Infect Control 32 (2004), 282–286.
137. 137 Dixon, R.E., Investigation of endemic and epidemic nosocomial infection data. Bennett, J.L., Brachman, P., (eds.) Hospital infection, 3rd ed., 1992, Little Brown, Boston, MA, 109–135.
138. 138 ASGE Standards of Practice Committee, Banerjee, S., Nelson, D.B., Dominitz, J.A., Reprocessing failure. Gastrointest Endosc 66 (2007), 869–871.
139. 139 Rutala, W.A., Weber, D.J., How to assess risk of disease transmission to patients when there is a failure to follow recommended disinfection and sterilization guidelines. Infect Control Hosp Epidemiol 28 (2007), 146–155.
140. 140 Food and Drug Administration. Medical device reporting (MDR). 2009. Available at: http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm. Accessed January 1, 2016.